Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Research grants | | | | | 1.0 | 0.3 | 0.7 | 1.4 |
| Collaborative research agreements | | | | | 0.1 | 0.4 | 0.3 | 0.8 |
| Total revenues [+] | 101.5 | 145.0 | 1.5 | 0.9 | 1.0 | 0.8 | 0.9 | 2.1 |
| Royalties | | | | | 30.2 | 41.6 | 10.5 | 7.0 |
| Products | 62.4 | 21.5 | | | | | | |
| Other | 0.0 | 0.7 | 1.5 | | | | | |
| Revenue growth [+] | -30.0% | 9693.4% | 65.8% | -12.8% | 33.4% | -17.8% | -56.5% | -99.8% |
| Research grants | | | | | 191.8% | -50.7% | -50.1% | -99.7% |
| Collaborative research agreements | | | | | -88.5% | 69.1% | -67.6% | -99.9% |
| Cost of goods sold | 5.5 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 96.0 | 143.5 | 1.5 | 0.9 | 1.0 | 0.8 | 0.9 | 2.1 |
| Gross margin | 94.6% | 98.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative [+] | 135.2 | 87.1 | 17.6 | 9.1 | 8.0 | 7.4 | 3.5 | 2.8 |
| Sales and marketing | 23.2 | 6.6 | | | 1.3 | 2.0 | | |
| General and administrative | 112.0 | 80.6 | | | 6.7 | 5.4 | 3.5 | 2.8 |
| Research and development | 45.2 | 43.1 | 32.8 | 34.4 | | | | |
| Equity in earnings | -1.8 | | | | | | | |
| Other operating expenses | -17.3 | 7.6 | | | 30.2 | 41.6 | 10.5 | 7.0 |
| EBITDA [+] | -68.0 | 6.2 | -48.6 | -42.4 | -36.9 | -47.9 | -12.6 | -6.8 |
| EBITDA growth | -1203.7% | -112.7% | 14.6% | 14.8% | -22.9% | 281.0% | 85.0% | -99.9% |
| EBITDA margin | -67.0% | 4.3% | -3280.4% | -4747.9% | -3608.3% | -6245.7% | -1347.7% | -316.6% |
| Depreciation and amortization | 0.9 | 0.5 | 0.3 | 0.2 | 0.2 | 0.3 | 0.5 | 0.9 |
| EBIT [+] | -68.9 | 5.6 | -48.9 | -42.6 | -37.1 | -48.2 | -13.1 | -7.7 |
| EBIT growth | -1322.0% | -111.5% | 14.7% | 14.7% | -22.9% | 268.8% | 70.2% | -99.9% |
| EBIT margin | -67.9% | 3.9% | -3301.1% | -4772.1% | -3629.8% | -6283.0% | -1400.8% | -357.9% |
| Non-recurring items [+] | 23.8 | | | | | | | |
| Unusual expense | 23.8 | | | | | | | |
| Other income (expense), net | 56.1 | 2.2 | 1.6 | 42.6 | 1.6 | 2.1 | 1.2 | 0.2 |
| Pre-tax income | -36.6 | 7.9 | -47.3 | 0.0 | -35.6 | -46.1 | -11.9 | -7.4 |
| Income taxes | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.8% | 0.3% | 0.0% | | 0.0% | 0.0% | 0.0% | 0.0% |
| Minority interest | 0.3 | 1.9 | 1.2 | 0.1 | | | | |
| Net income | -37.0 | 7.8 | -47.3 | -42.1 | -35.6 | -46.1 | -12.2 | -7.7 |
| Net margin | -36.4% | 5.4% | -3197.8% | -4715.5% | -3477.2% | -6014.2% | -1310.8% | -357.2% |
| |
| Basic EPS [+] | ($0.78) | $0.17 | ($1.25) | ($1.30) | ($1.24) | $0.00 | ($4.81) | ($3.22) |
| Growth | -555.8% | -113.7% | -3.5% | 4.5% | 58290.3% | -100.0% | 49.5% | -32.4% |
| Diluted EPS [+] | ($0.78) | $0.17 | ($1.25) | ($1.30) | ($1.24) | $0.00 | ($4.81) | ($3.22) |
| Growth | -564.6% | -113.4% | -3.5% | 4.5% | 58290.3% | -100.0% | 49.5% | -32.4% |
| |
| Shares outstanding (basic) [+] | 47.3 | 45.6 | 37.8 | 32.5 | 28.7 | 21,715.3 | 2.5 | 2.4 |
| Growth | 3.7% | 20.6% | 16.5% | 13.2% | -99.9% | 853861.7% | 6.7% | -99.9% |
| Shares outstanding (diluted) [+] | 47.3 | 46.5 | 37.8 | 32.5 | 28.7 | 21,715.3 | 2.5 | 2.4 |
| Growth | 1.8% | 22.9% | 16.5% | 13.2% | -99.9% | 853861.7% | 6.7% | -99.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|